Praxis Precision Medicines, Inc.

Healthcare · Biotechnology · United States

Last price 288.62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 8.06B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company’s platforms include Cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and Solidus to discover and develop antisense oligonucleotide. It also develops ulixacaltamide, a small molecule inhibitor of T-type calcium channels that in N...